(Q44100198)

29 November 2017

title

Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites (English)

1 reference

29 November 2017

Gianmario Borroni

1

1 reference

29 November 2017

Francesco Salerno

2

1 reference

29 November 2017

Massimo Cazzaniga

3

1 reference

29 November 2017

Franco Bissoli

4

1 reference

29 November 2017

Elettra Lorenzano

5

1 reference

29 November 2017

Alessandra Maggi

6

1 reference

29 November 2017

Stefania Visentin

7

1 reference

29 November 2017

Anna Panzeri

8

1 reference

29 November 2017

Roberto de Franchis

9

1 reference

29 November 2017

publication date

1 September 2002

1 reference

29 November 2017

published in

Journal of Hepatology

1 reference

29 November 2017

volume

37

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

315-321

1 reference

A controlled study of the prophylactic portacaval shunt. A final report

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Prophylactic portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

PROPRANOLOL IN DECOMPENSATED ALCOHOLIC CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Portal hemodynamics during nitroglycerin administration in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

New approaches in the pharmacologic treatment of portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Liver disease, carbohydrate metabolism and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Nitrovasodilators and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Renal function and effective beta-blockade in cirrhosis with ascites. Relationship with baseline sympathoadrenergic tone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900174-5

7 January 2021

10.1016/S0168-8278(02)00174-5

Identifiers

DOI

1 reference

29 November 2017

1 reference